CliffBio
small molecule

CINACALCET HYDROCHLORIDE

CINACALCET HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyJEROME STEVENS PHARMACEUTICALS INC

Drug detail

Brand nameCINACALCET HYDROCHLORIDE
Active ingredientCINACALCET HYDROCHLORIDE
StrengthEQ 30MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2021
Marketing statusDISCN

More from JEROME STEVENS PHARMACEUTICALS INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CINACALCET HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio